LadRx Corporation (LADX)
OTCMKTS
· Delayed Price · Currency is USD
1.620
+0.090 (5.88%)
Mar 31, 2025, 4:00 PM EST
LadRx Employees
LadRx had 2 employees as of December 31, 2023. The number of employees decreased by 1 or -33.33% compared to the previous year.
Employees
2
Change (1Y)
-1
Growth (1Y)
-33.33%
Revenue / Employee
n/a
Profits / Employee
-$794,843
Market Cap
802.05K
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Endo Inc. | 3,116 |
Elite Pharmaceuticals | 64 |
Glass House Brands | 413 |
Northwest Biotherapeutics | 25 |
CytoDyn | 9 |
American Oncology Network | 1,525 |
Longduoduo Company | 49 |
LadRx News
- 20 days ago - LadRx Corporation, Inc. to Present at the Virtual Life Science Investor Forum March 13th - GlobeNewsWire
- 3 months ago - LadRx Planning NDA Submission under 505(b)(2) for Aldoxorubicin and Other Updates - Business Wire
- 1 year ago - LadRx Issues 2024 Update to Shareholders - Business Wire